Estimated incidence, mortality and 5-year prevalence: both sexes

Cancer

Incidence Mortality 5-year prevalence

Number (%) Number (%) Number (%)

5329 1.8 2.3 2250 1.2 1.0 12007 1.9

13084 4.4 5.6 7391 3.8 3.3 35142 5.5

2034 0.7 0.9 1602 0.8 0.7 4603 0.7

2191 0.7 1.0 2023 1.0 0.9 1917 0.3

6011 2.0 2.8 5406 2.8 2.5 7597 1.2

27772 9.3 12.8 18398 9.5 8.6 57892 9.0

18121 6.0 8.4 17175 8.8 8.0 10687 1.7

1644 0.5 0.8 1538 0.8 0.7 1799 0.3

5829 1.9 2.7 5642 2.9 2.6 4009 0.6

2657 0.9 1.2 1240 0.6 0.6 6887 1.1

34696 11.6 16.3 30904 15.9 14.6 28468 4.4

1069 0.4 0.5 543 0.3 0.3 2735 0.4

50 0.0 0.0 30 0.0 0.0 104 0.0

48998 16.4 40.3 19750 10.2 16.6 171005 26.5

20928 7.0 17.3 9498 4.9 8.2 59107 9.2

6475 2.2 5.6 1947 1.0 1.7 24616 3.8

10238 3.4 8.4 7075 3.6 6.1 25185 3.9

13663 4.6 14.8 9191 4.7 9.8 35193 5.5

1676 0.6 1.4 851 0.4 0.8 4519 0.7

3225 1.1 1.5 2459 1.3 1.2 6777 1.1

6978 2.3 3.2 3599 1.9 1.7 17794 2.8

4903 1.6 2.1 3402 1.7 1.5 7121 1.1

7816 2.6 3.3 3103 1.6 1.5 29557 4.6

1168 0.4 0.5 687 0.4 0.3 3624 0.6

13327 4.4 6.0 8963 4.6 4.2 21089 3.3

2318 0.8 1.1 1939 1.0 0.9 3616 0.6

9841 3.3 4.3 8479 4.4 3.7 8170 1.3

299673 100.0 133.5 194528 100.0 89.3 644624 100.0

Incidence and mortality data for all ages. 5-year prevalence for adult population only.

ASR (W) and proportions per 100,000.

Age-standardised rate (W):

ASR (W) ASR (W)

 Lip, oral cavity

 Nasopharynx

 Other pharynx

 Oesophagus

 Stomach

 Colorectum

 Liver

 Gallbladder

 Pancreas

 Larynx

 Lung

 Melanoma of skin

 Kaposi sarcoma

 Breast

 Cervix uteri

 Corpus uteri

 Ovary

 Prostate

 Testis

 Kidney

 Bladder

 Brain, nervous system

 Thyroid

 Hodgkin lymphoma

 Non-Hodgkin lymphoma

 Multiple myeloma

 Leukaemia

 All cancers excl. non-melanoma skin cancer

A rate is the number of new cases or deaths per 100 000 persons per year. An age-standardised rate is the rate that a population would have if it had a standard age structure. Standardization is necessary when comparing several populations that differ with respect to age because age has a powerful influence on the risk of cancer.

Risk of getting or dying from the disease before age 75 (%):

Incidence

Mortality

Data source: no data.

Prevalence

The probability or risk of individuals getting/dying from cancer. It is expressed as the number of new born children (out of 100) who would be expected to develop/die from cancer before the age of 75 if they had cancer rates (in the absence of other causes of death).

Data source: frequency data.

Method: estimated as the weighted average of the local rates

Method: estimated from national incidence estimates using modelled survival

Prevalence was estimated from incidence estimates and regional average of observed survival by cancer and age group

Estimated incidence, mortality and 5-year prevalence: both sexes

5-year prevalence INDONESIA Male FemaleProp. 122012 122756

6.7 138.8 160.8

19.5 136.2 134.4

2.5 14.4 13.8

1.1

4.2

32.1 102.7 91.8

5.9 103.8 78.5

1.0 11.0 8.6

2.2

3.8

15.8 234.9 409.7

1.5 263.6 449.8

0.1

187.7 Lung Breast

64.9 Colorectum Cervix uteri

27.0 Prostate Colorectum

27.6 Liver Ovary

39.5 Nasopharynx Lung

5.1

3.8

9.9

4.0

16.4

2.0

11.7

2.0

4.5

357.7

Age-standardised rate (W):

Population (thousands)

Number of new cancer cases (thousands)

  Age-standardised rate (W)

  Risk of getting cancer before age 75 (%)

Number of cancer deaths (thousands)

  Age-standardised rate (W)

  Risk of dying from cancer before age 75 (%)

5-year prevalent cases, adult population (thousands)

  Proportion (per 100,000)

5 most frequent cancers (ranking defined by total number of cases)

A rate is the number of new cases or deaths per 100 000 persons per year. An age-standardised rate is the rate that a population would have if it had a standard age structure. Standardization is necessary when comparing several populations that differ with respect to age

Risk of getting or dying from the disease before age 75 (%):

The probability or risk of individuals getting/dying from cancer. It is expressed as the number of new born children (out of 100) who would be expected to develop/die from cancer before the age of 75 if they had cancer rates (in the absence of other causes of death).

244769

299.7

133.5

14.0

194.5

89.3

9.7

644.6

357.7

Breast

Lung

Colorectum

Cervix uteri

Liver

Both sexes

Estimasi kejadian, kematian dan prevalensi 5 tahun: kedua jenis kelaminTahun 2012

Jenis KankerInsiden Kematian Prevalensi 5 tahun

Jumlah (%) Jumlah (%) Jumlah (%) Prop.

Bibir, rongga mulut 5329 1.8 2.3 2250 1.2 1.0 12007 1.9 6.7

nasofaring 13084 4.4 5.6 7391 3.8 3.3 35142 5.5 19.5

faring lainnya 2034 0.7 0.9 1602 0.8 0.7 4603 0.7 2.5

Esofagus 2191 0.7 1.0 2023 1.0 0.9 1917 0.3 1.1

perut 6011 2.0 2.8 5406 2.8 2.5 7597 1.2 4.2

colorectum 27772 9.3 12.8 18398 9.5 8.6 57892 9.0 32.1

hati 18121 6.0 8.4 17175 8.8 8.0 10687 1.7 5.9

kandung empedu 1644 0.5 0.8 1538 0.8 0.7 1799 0.3 1.0

pankreas 5829 1.9 2.7 5642 2.9 2.6 4009 0.6 2.2

pangkal tenggorokan 2657 0.9 1.2 1240 0.6 0.6 6887 1.1 3.8

paru-paru 34696 11.6 16.3 30904 15.9 14.6 28468 4.4 15.8

Melanoma kulit 1069 0.4 0.5 543 0.3 0.3 2735 0.4 1.5

sarkoma Kaposi 50 0.0 0.0 30 0.0 0.0 104 0.0 0.1

payudara 48998 16.4 40.3 19750 10.2 16.6 171005 26.5 187.7

uteri serviks 20928 7.0 17.3 9498 4.9 8.2 59107 9.2 64.9

Corpus uteri 6475 2.2 5.6 1947 1.0 1.7 24616 3.8 27.0

indung telur 10238 3.4 8.4 7075 3.6 6.1 25185 3.9 27.6

prostata 13663 4.6 14.8 9191 4.7 9.8 35193 5.5 39.5

testis 1676 0.6 1.4 851 0.4 0.8 4519 0.7 5.1

ginjal 3225 1.1 1.5 2459 1.3 1.2 6777 1.1 3.8

kandung kemih 6978 2.3 3.2 3599 1.9 1.7 17794 2.8 9.9

Otak, sistem saraf 4903 1.6 2.1 3402 1.7 1.5 7121 1.1 4.0

kelenjar gondok 7816 2.6 3.3 3103 1.6 1.5 29557 4.6 16.4

limfoma Hodgkin 1168 0.4 0.5 687 0.4 0.3 3624 0.6 2.0

Limfoma non-Hodgkin 13327 4.4 6.0 8963 4.6 4.2 21089 3.3 11.7

multiple myeloma 2318 0.8 1.1 1939 1.0 0.9 3616 0.6 2.0

Leukimia 9841 3.3 4.3 8479 4.4 3.7 8170 1.3 4.5

299673 100.0 133.5 194528 100.0 89.3 644624 100.0 357.7

Age-Standardised Rate (W) dan proporsi per 100,000.

ASR (W) ASR (W)

Semua kanker excl. kanker kulit non-melanoma

Kejadian dan kematian data untuk segala usia. Prevalensi 5 tahun untuk populasi orang dewasa saja.

  Age-standardised rate (W)

A rate adalah jumlah kasus baru atau kematian per 100.000 orang per tahun. Tingkat usia-standar adalah tingkat populasi akan memiliki jika memiliki struktur umur standar. Standardisasi ini diperlukan ketika membandingkan beberapa populasi yang berbeda sehubungan dengan usia karena usia memiliki pengaruh kuat pada risiko kanker.

Risiko terkena atau meninggal akibat penyakit ini sebelum usia 75 (%):

insidensiSumber data: Data frekuensi.Metode: diperkirakan sebagai rata-rata tertimbang dari tingkat lokalmortalitasSumber data: data tidak.Metode: diperkirakan dari perkiraan insiden nasional menggunakan survival dimodelkankelazimanPrevalensi diperkirakan dari perkiraan kejadian dan rata-rata regional hidup diamati oleh kanker dan kelompok usia

Probabilitas atau risiko individu terkena/kematian akibat kanker. Hal ini dinyatakan sebagai jumlah anak yang baru lahir (dari 100) yang akan diharapkan untuk bangkit / meninggal karena kanker sebelum usia 75 jika mereka memiliki tingkat kanker (tanpa adanya penyebab lain kematian).

INDONESIA Laki-laki Perempuan Kedua Jenis Kelamin

122012 122756 244769

138.8 160.8 299.7

136.2 134.4 133.5

14.4 13.8 14.0

102.7 91.8 194.5

103.8 78.5 89.3

11.0 8.6 9.7

234.9 409.7 644.6

263.6 449.8 357.7

paru-paru payudara payudara

colorectum uteri serviks paru-paru

prostata colorectum colorectum

hati indung telur uteri serviks

nasofaring paru-paru hati

http://globocan.iarc.fr/Pages/fact_sheets_population.aspx?country=360

Populasi (ribuan)

Jumlah kasus baru kanker (ribuan)

  Age-standardised rate (W)

Risiko terkena kanker sebelum umur 75 (%)

Jumlah kematian akibat kanker (ribuan)

  Age-standardised rate (W)

Risiko terkena kanker sebelum umur 75 (%)

Prevalensi kasus per 5 tahun, popolusi dewasa (ribuan)

  Proporsi (per 100,000)

5 kanker yang paling sering (ranking ditentukan oleh jumlah total kasus)

Prevalensi diperkirakan dari perkiraan kejadian dan rata-rata regional hidup diamati oleh kanker dan kelompok usia

30795693

432168605

9374946106187

1417

3792526

20

2924811430

452831634472

825766

337915014713

481

4364379

1362

105145